Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation

Journal article

JD Gunst, K Kjær, R Olesen, TA Rasmussen, L Østergaard, PW Denton, OS Søgaard, M Tolstrup

Journal of Virus Eradication | Published : 2019